Barbara most recently served Novo Nordisk, Inc as a Director of External Innovation Sourcing for the company’s Global Research Unit. Barbara served on the faculty of the University of Utah’s Department of Pathology as Associate Professor. In addition to her academic career, she was Vice President of Development at StemCells Inc., where she was responsible for directing the effort to bring the company’s neural cell-based product candidate from the exploratory and preclinical proof of principle stages into clinical development under the FDA regulatory process. Prior to joining StemCells, Barbara was a scientific co-founder and Senior Vice President of Research and Development at Pharmadigm, a privately held biopharmaceutical company with several products discovered at the company and developed for various stages of clinical development for inflammatory conditions. Barbara obtained her doctorate in Cellular Immunology from the University of Rochester and completed postdoctoral training at Washington University School of Medicine and the Department of Microbiology at UCLA. In addition to a doctorate degree, Araneo holds certification in US Regulatory Affairs.